Use of myocardin in the classification of mesenchymal tumors of the uterus
- PMID: 19952936
- DOI: 10.1097/PGP.0b013e3181b1cdb0
Use of myocardin in the classification of mesenchymal tumors of the uterus
Abstract
It can sometimes be difficult to distinguish between the 2 main types of uterine mesenchymal neoplasms; uterine smooth muscle tumors (SMTs) and endometrial stromal sarcomas (ESSs), particularly when the ESSs show smooth muscle differentiation or the SMTs are highly cellular. The aim of this study was to investigate myocardin expression in normal uterus myometrium, in SMTs, and in ESSs and to determine whether myocardin can be used as a useful diagnostic tool in the classification of problematic uterine mesenchymal tumors. Immunohistochemical staining was performed in each group. Besides myocardin, all cases were also stained for other smooth muscle markers (h-caldesmon, desmin, smooth muscle actin) and for CD10. All tested markers were analyzed in 21 conventional leiomyomas (LMs), 21 highly cellular leiomyomas (HCLs), 12 leiomyosarcomas (LMSs), 3 endometrial stromal nodules (ESNs), 11 ESSs, and 15 normal uterus myometrium. Myocardin was expressed in all normal uterine myometrium and in SMTs (even in the regions with epithelioid features) moderately or strongly, at least topically, whereas in endometrium, in ESNs and in ESSs, except in the regions of smooth muscle differentiation, it was negative. All ESNs, 11 of 11 ESSs and 14 of 15 endometrium were negative for h-caldesmon, but all SMTs and normal uterine myometrium were positive for h-caldesmon except for 2 LMSs, 2 HCLs, and for the regions with epithelioid features in 2 LMs. Desmin was stained in all normal uterine myometrium and in SMTs (except those of the regions with epithelioid features), but it was negative in 1 HCL and 1 LMS. One of 3 ESNs and 2 of 11 ESSs were expressed in desmin. Smooth muscle actin was negative in all ESNs, 2 LMSs, and 2 HCLs, and positive in all myometriums, LMs (except for the regions with epithelioid features), 1 ESSs, and 1 proliferative phase endometrium. Eight of 11 ESSs and all ESNs were positive for CD10, as was 1 HCL, and 2 LMSs. All uterine myometrium, 3 ESSs, and 3 endometriums were negative for CD10. Our study indicates that the myocardin is expressed in normal and neoplastic uterine smooth muscle cells sensitively and that the evaluation of myocardin expression is useful in distinguishing SMTs from ESSs.
Similar articles
-
Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.Am J Surg Pathol. 2006 Mar;30(3):319-27. doi: 10.1097/01.pas.0000188029.63706.31. Am J Surg Pathol. 2006. PMID: 16538051
-
Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.Am J Surg Pathol. 2003 Nov;27(11):1458-62. doi: 10.1097/00000478-200311000-00009. Am J Surg Pathol. 2003. PMID: 14576480
-
[Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].J Gynecol Obstet Biol Reprod (Paris). 2008 Sep;37(5):457-62. doi: 10.1016/j.jgyn.2008.05.002. Epub 2008 Jun 18. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18565690 French.
-
Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations.Int J Gynecol Pathol. 2014 Jul;33(4):374-84. doi: 10.1097/PGP.0000000000000141. Int J Gynecol Pathol. 2014. PMID: 24901397 Review.
-
Uterine sarcomas: a review.Gynecol Oncol. 2010 Jan;116(1):131-9. doi: 10.1016/j.ygyno.2009.09.023. Epub 2009 Oct 23. Gynecol Oncol. 2010. PMID: 19853898 Review.
Cited by
-
Dicing up microRNA gene expression profiles in normal and neoplastic smooth muscle cells.Am J Pathol. 2010 Aug;177(2):541-3. doi: 10.2353/ajpath.2010.100479. Epub 2010 Jun 21. Am J Pathol. 2010. PMID: 20566744 Free PMC article.
-
Mechanistic Study of the Inhibitory Effect of Kaempferol on Uterine Fibroids In Vitro.Med Sci Monit. 2016 Dec 8;22:4803-4808. doi: 10.12659/msm.898127. Med Sci Monit. 2016. PMID: 27928147 Free PMC article.
-
Recent progress regarding kaempferol for the treatment of various diseases.Exp Ther Med. 2019 Oct;18(4):2759-2776. doi: 10.3892/etm.2019.7886. Epub 2019 Aug 13. Exp Ther Med. 2019. PMID: 31572524 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical